Previous Page  22 / 25 Next Page
Information
Show Menu
Previous Page 22 / 25 Next Page
Page Background

Gastro Education 2018

Journal of Clinical Gastroenterology and Hepatology

ISSN: 2575-7733

Page 62

September 06-07, 2018

London, UK

14

th

International Conference on

Gastro Education

S

ince the dawn of the Post-Genomic era (25 years back),

applying a genetic approach to solving various intricate

problems/issues in research has taken-off even more swiftly

than ever before. Spatio-temporal cues defined for certain critical

components in a particular developmental pathway (involved in

causing/progression of certain disease) provide a firm basis for

detecting the order, hierarchy and “switching-off or on” of genes

that regulate it. The various time-points, at which genes are

switched on/off, clearly determines the fate of what a cell does

in terms of being functional or non-functional, due to disruption

of that specific pathway. Recent research-work in this area

(Bhojwani, 2015) provides strong evidence, toward identifying

such components (associated with Wnt-signaling involved in

Colorectal Cancer-CRC disease). These crucial elements indeed

determined the genetic transformation of a “blank-slate” (“cells

of origin” and/or putative “cancer stem cells”) or “primitive-state”

epithelial cells to an intermediate adenoma/polyp (dyspastic),

and later to a proliferative (hyperplastic) or cancerous (neoplastic)

state. The idea is to re-iterate the power of genetics, in solving and

filling the missing links of any developmental pathway involved in

progression of a disease (in this case, CRC). A critical temporal

requirement of certain molecules [Caesin-Kinase I (CKI) and

Human-Discs-large (hDlg)] was finally established and these

proteins were identified as “early” and “late” acting molecules

respectively, in a very crucial developmental event, that basically

transforms “polyps” to full-fledged “carcinomas” (epithelial

cancers) in COLORECTAL tumors. The detection of these genetic

and developmental parameters, served as a focal-point and a

prominent diagnostic feature, for detection of effects, ie. gain/

loss of other components involved during progression of CRC

disease. Coincidentally, the chromosomes on which these genes

reside have been found to be dense and rich in SNPs (hot-spots),

the details of which were published in a separate report (Patidar

& Bhojwani, 2013). This work harnessed the potential of Genetics,

Developmental Biology and Bio-Informatics tools to solve a long-

standing puzzle in pin-pointing some genetic factors that were

critically involved in the progression of CRC disease. The report

has created enough impact, in terms of authentically suggesting,

that it is only when we deploy a combinatorial approach towards

certain complicated biological problems, can we successfully

unveil the underlying mechanisms in greater details. However, it

is now conceived that, at the heart of every tumor lies a rare sub-

population of cells (Cancer Stem Cells-CSCs), which give rise to

most of theCancersandarenowthe targetsof investigation. Since

no definitive markers or efficient labeling tools are available, this

population of cells still remains elusive in both cancer and stem

cell biology. Therefore, it would be critical to understandmolecular

differences between stem cells and cancer cells, which might

be helpful in providing novel insights into the mechanism

of tumorigenesis as well as potential therapeutic targets, in

foreseeable future. We have come a long way in the stem cell

advances over time. Very recent breakthroughs include: (a) The

tuning and genetic re-programming of stem cells (iPS cells) by a

handful of genetic factors (Takahashi et al, 2006, 2007; discussed

in Bhojwani, 2008) and; (b) The transformation of cancerous cells

to normal cells by reversing the genetic changes involved and

also restricting the awry cancerous cells by using microRNAs

(http://yournewswire.com/breakthrough-scientists-find-way-to-

change-cancer-cells-into-healthy-cells/). My talk would shed light

on how we could intelligently utilize these efficient tools together,

to attack the “Bad seeds” in ways to cure the myriad diseases,

like Cancer.

jbhojwani2005@gmail.com

Impact of deploying a genetic approach to stem cells opens-up

new facets in the blank slates of our body

Jyoti Bhojwani

DAVV, India

J Clin Gastroenterol Hepatol 2018, Volume 2

DOI: 10.21767/2575-7733-C2-006